229 related articles for article (PubMed ID: 21412087)
1. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic Acid-enhanced magnetic resonance imaging findings of borderline lesions at high risk for progression to hypervascular classic hepatocellular carcinoma.
Kobayashi S; Matsui O; Gabata T; Koda W; Minami T; Ryu Y; Kawai K; Kozaka K
J Comput Assist Tomogr; 2011; 35(2):181-6. PubMed ID: 21412087
[TBL] [Abstract][Full Text] [Related]
2. Intranodular signal intensity analysis of hypovascular high-risk borderline lesions of HCC that illustrate multi-step hepatocarcinogenesis within the nodule on Gd-EOB-DTPA-enhanced MRI.
Kobayashi S; Matsui O; Gabata T; Koda W; Minami T; Ryu Y; Kozaka K; Kitao A
Eur J Radiol; 2012 Dec; 81(12):3839-45. PubMed ID: 22884705
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: initial experience.
Lee SA; Lee CH; Jung WY; Lee J; Choi JW; Kim KA; Park CM
Magn Reson Imaging; 2011 Jan; 29(1):83-90. PubMed ID: 20832227
[TBL] [Abstract][Full Text] [Related]
4. Relationship between signal intensity on hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MR imaging and prognosis of borderline lesions of hepatocellular carcinoma.
Kobayashi S; Matsui O; Gabata T; Koda W; Minami T; Ryu Y; Kozaka K; Kitao A
Eur J Radiol; 2012 Nov; 81(11):3002-9. PubMed ID: 22748558
[TBL] [Abstract][Full Text] [Related]
5. Evolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhanced MRI.
Kumada T; Toyoda H; Tada T; Sone Y; Fujimori M; Ogawa S; Ishikawa T
AJR Am J Roentgenol; 2011 Jul; 197(1):58-63. PubMed ID: 21701011
[TBL] [Abstract][Full Text] [Related]
6. Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma.
Ichikawa S; Ichikawa T; Motosugi U; Sano K; Morisaka H; Enomoto N; Matsuda M; Fujii H; Araki T
J Magn Reson Imaging; 2014 Feb; 39(2):293-7. PubMed ID: 23633285
[TBL] [Abstract][Full Text] [Related]
7. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
[TBL] [Abstract][Full Text] [Related]
8. Hypointense hepatocellular nodules on hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI: can increasing the flip angle improve conspicuity of lesions?
Tamada T; Ito K; Yamamoto A; Yasokawa K; Higaki A; Kanki A; Sato T; Tanimoto D; Higashi H
J Magn Reson Imaging; 2013 May; 37(5):1093-9. PubMed ID: 23148032
[TBL] [Abstract][Full Text] [Related]
9. Hypovascular hepatic nodules showing hypointense on the hepatobiliary-phase image of Gd-EOB-DTPA-enhanced MRI to develop a hypervascular hepatocellular carcinoma: a nationwide retrospective study on their natural course and risk factors.
Inoue T; Hyodo T; Murakami T; Takayama Y; Nishie A; Higaki A; Korenaga K; Sakamoto A; Osaki Y; Aikata H; Chayama K; Suda T; Takano T; Miyoshi K; Koda M; Numata K; Tanaka H; Iijima H; Ochi H; Hirooka M; Imai Y; Kudo M
Dig Dis; 2013; 31(5-6):472-9. PubMed ID: 24281023
[TBL] [Abstract][Full Text] [Related]
10. Optimal scanning protocol of arterial dominant phase for hypervascular hepatocellular carcinoma with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR.
Kagawa Y; Okada M; Kumano S; Katsube T; Imaoka I; Tanigawa N; Ishii K; Kudo M; Murakami T
J Magn Reson Imaging; 2011 Apr; 33(4):864-72. PubMed ID: 21448951
[TBL] [Abstract][Full Text] [Related]
11. Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study.
Inoue T; Hyodo T; Korenaga K; Murakami T; Imai Y; Higaki A; Suda T; Takano T; Miyoshi K; Koda M; Tanaka H; Iijima H; Ochi H; Hirooka M; Numata K; Kudo M
J Gastroenterol; 2016 Feb; 51(2):144-52. PubMed ID: 26373860
[TBL] [Abstract][Full Text] [Related]
12. Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy.
Toyoda H; Kumada T; Tada T; Niinomi T; Ito T; Sone Y; Kaneoka Y; Maeda A
J Hepatol; 2013 Jun; 58(6):1174-80. PubMed ID: 23376360
[TBL] [Abstract][Full Text] [Related]
13. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of the peritumoral decreased uptake area of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid in hepatocellular carcinoma.
Nishie A; Asayama Y; Ishigami K; Kakihara D; Nakayama T; Ushijima Y; Takayama Y; Shirabe K; Fujita N; Kubo Y; Hirakawa M; Honda H
J Gastroenterol Hepatol; 2014 Mar; 29(3):561-7. PubMed ID: 24219648
[TBL] [Abstract][Full Text] [Related]
15. Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma?
Kudo M
Oncology; 2010 Jul; 78 Suppl 1():87-93. PubMed ID: 20616589
[TBL] [Abstract][Full Text] [Related]
16. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
[TBL] [Abstract][Full Text] [Related]
17. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
[TBL] [Abstract][Full Text] [Related]
18. High-risk nodules detected in the hepatobiliary phase of Gd-EOB-DTPA-enhanced MR imaging in cirrhosis or chronic hepatitis: incidence and predictive factors for hypervascular transformation, preliminary results.
Higaki A; Ito K; Tamada T; Teruki S; Yamamoto A; Higashi H; Kanki A; Sato T; Noda Y
J Magn Reson Imaging; 2013 Jun; 37(6):1377-83. PubMed ID: 23172841
[TBL] [Abstract][Full Text] [Related]
19. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
Kim JE; Kim SH; Lee SJ; Rhim H
AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
[TBL] [Abstract][Full Text] [Related]
20. Timing of the hepatic arterial phase at Gd-EOB-DTPA-enhanced hepatic dynamic MRI: comparison of the test-injection and the fixed-time delay method.
Nakamura S; Nakaura T; Kidoh M; Utsunomiya D; Doi Y; Harada K; Uemura S; Yamashita Y
J Magn Reson Imaging; 2013 Sep; 38(3):548-54. PubMed ID: 23744782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
